Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

How drugmakers are working to get paid for their most expensive treatments

New medical treatments such as gene therapies come with a high price tag up to six figures, and drugmakers are working hard to ensure they can get reimbursed for these medicines in creative ways.

Thumbnail

Digital health funding slowed in 2019

Global venture capital funding in digital health dropped 6% in 2019, with 615 deals nabbing $8.9 billion in capital.

Thumbnail

Teladoc acquires InTouch for $600M

Virtual care provider Teledoc Health will acquire InTouch Health for the purchase price of $600M.

Thumbnail

ACO savings are clear, but participation drops

Accountable care organizations are increasingly saving Medicare more money, but after the Trump administration made significant changes to the Medicare Shared Savings Program, fewer of these organizations are participating, according to data from the National Association of Accountable Care Organizations (NAACOS).

Thumbnail

Sky-high drug prices could hurt Republicans in 2020

Drug prices are still rising, with manufacturers hiking up prices at the start of 2020. And the “reluctance” from the Republican party to challenge those rising prices could become a huge liability for the upcoming 2020 election, according to The Hill.

Thumbnail

Drug price inflation slows under investor strategy

Drug prices are still rising in 2020, but the rate of inflation appears to be slowing down. For investors, however, that might be good news, according to The Wall Street Journal.

Thumbnail

Hospital charges are driving higher payments

Hospital charges are on their way up, driving up private payments that are already significantly higher than public payments, according to a new study published in Health Affairs. However, the widening gap between private and public payments appears to be slowing down.

 

Thumbnail

CVS, Walgreens, others sue doctors over opioid crisis role

A handful of major drugstore retailers are suing Ohio doctors over their role in the national opioid abuse and overdose epidemic, claiming pharmacies alone shouldn't be found liable in litigation.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup